Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on the day's biggest business stories
Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Photo: Axios
The U.S. needs to ramp up the use of rapid COVID-19 testing in order to curb the pandemic and prepare for reopening, two public health experts said on Wednesday during an Axios virtual event.
Why it matters: Experts warn that vaccinations likely do not provide long-term immunity and that the pandemic is far from over. Jennifer Nuzzo of Johns Hopkins, and Michael Mina of Harvard's Kennedy School of Public Health, say mass testing will be imperative to tracking outbreaks and containing the virus in the coming months.
- “Testing informs our understanding of what's going on at all levels, from the personal—knowing that today is not the day to go and visit my vulnerable relatives because I'm infected—to the national, trying to understand, is the situation in the U.S. getting better? Is it worse?” Nuzzo said.
What they're saying: "We need rapid tests that are ubiquitous, that we can use in lots of different places, and at a volume that will enable repeat testing. And we also need them to be much more inexpensive than they are right now," Nuzzo said.
- "Some of the cheapest rapid tests are about $5 each, which is extraordinarily low cost in the scheme of things, and particularly compared to laboratory testing" she added. "But there are 15 million public school children in the U.S. And so even if you were to test all of the ones, that would be a prohibitive cost."
- "[I]n the midst of a pandemic, we can switch the purpose of testing from just purely a diagnostic test to actually a test that is going to help mitigate spread at the community level....the only way to make that a reality is to get the tests away from being prescription-use only, make them smaller, simpler and tests that people could be using at home," Mina said.
Mina also supported the use of rapid, at-home COVID-19 tests as schools and workplaces reopen, even though at-home tests may not be as accurate as laboratory testing.
- "If people walking into that building use a test at home before work, or at the doorway before school, whatever that might be, it can reduce any chances of spread, say, 90 percent. And that is a major win."
- "It's not perfect, but nothing in this pandemic is perfect. But a reduction by 90 percent would be a massive benefit to make everyone feel safer."